Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 29, 2007

FDA Approves Roche’s West Nile Virus Blood Screening Test

  • The FDA approved Roche’s BLA related to its test for direct detection of West Nile virus in donated human blood and plasma. West Nile can be transmitted by transfusion of infected blood or blood products.

    The test, called the cobas TaqScreen West Nile Virus Test, enables detection of the virus earlier in the infection cycle in donors who may show no symptoms of disease, according to the company.

    The test is designed to run on the cobas 201 system, Roche’s flexible, modular instrument platform that automates each step of the real-time PCR blood screening process. The test uses Roche’s PCR technology to detect the genetic material of the West Nile virus directly in blood.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »